Hereditary Angioedema Prophylaxis: Lanadelumab and Garadacimab Outcomes Look Nearly Identical, Letter Argues
A letter to the editor in Drugs in R&D argues that a network meta-analysis overstated garadacimab's advantage, since lanadelumab every ...
Tag: PRISMA-NMA
POPULAR NEWS
-
Gut microbes linked to Alzheimer’s, Parkinson’s, Huntington’s and ALS
-
Lipid emulsions as antidotes: a 2025 review maps promise and limits in drug poisoning
-
Grape pomace bread boosts fiber and antioxidants but tests taste limits
-
TGF-β signaling symposium reveals new paths from development to cancer therapy